Innovative Drug Discovery and Development
Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.
A COVID-19 Collaboration as Big as Texas
Drug discovery researchers from El Paso to Galveston join forces to find new therapeutics to combat the pandemic.
Artificial Intelligence Shakes Up Drug Discovery
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Leaf Huang, University of North Carolina; Stephan Schmidt University of Florida; Elisabeth Martinez, Univ. of Texas Southwestern; Robert YL Tsai, Texas A&M Institute of BioSciences and Technology.Find out more »
Please save the date for this exciting conference and stay tuned for speaker updates. James Inglese, NIH/NCATS is confirmed. More information can be found on the conference website.Find out more »